Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Katrín Ásta Gunnarsdóttir"'
Autor:
Frida Smith, Lisa Vaughn, Andreas Hellström, Erik Eriksson, Katrín Ásta Gunnarsdóttir, Anna Genell, Carina Mannefred, Thomas Björk-Eriksson
Publikováno v:
BMJ Open Quality, Vol 10, Iss 4 (2021)
Objective Kraftens Hus is the first support centre in Sweden designed by and for people affected by cancer, including patients, family, friends, staff members and local community representatives (collectively ‘stakeholders’). The purpose of this
Externí odkaz:
https://doaj.org/article/431d89e03caa41c1a0c0ab422bea0750
Autor:
Frida Smith, Ulf Lönqvist, Daniel McLinden, Herman Nilsson-Ehle, Thomas Björk-Eriksson, Hege Garelius, Katrín Ásta Gunnarsdóttir, Anna Genell, Lisa M. Vaughn
Publikováno v:
International journal for quality in health care : journal of the International Society for Quality in Health Care. 31(7)
Quality problem or issue Within healthcare, policy documents are often used to strategically standardize, streamline or change how general health issues are managed for a specific patient group or treatment. Despite significant effort in developing p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::96641b28cb65d07bb881a970cbb114f6
https://pubmed.ncbi.nlm.nih.gov/30576515
https://pubmed.ncbi.nlm.nih.gov/30576515
Autor:
Yvonne Wettergren, Elinor Bexe Lindskog, Katrín Ásta Gunnarsdóttir, Bengt Glimelius, Kristoffer Derwinger, Karl Kodeda
Publikováno v:
BMC Cancer
Background The value of adjuvant chemotherapy in colorectal cancer is well studied, and guidelines have been established. Little is known about how treatment guidelines are implemented in the everyday clinical setting. Methods This national populatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a164a84d723fe03ca31ecbcb407bc44a
http://europepmc.org/articles/PMC4301907
http://europepmc.org/articles/PMC4301907
Autor:
Szilard Nemes, Toshima Z. Parris, Katrín Ásta Gunnarsdóttir, Emman Shubbar, Shahin Hajizadeh, Anikó Kovács, Khalil Helou, Per Karlsson, Zakaria Einbeigi
Publikováno v:
Europe PubMed Central
BMC Cancer
BMC Cancer, Vol 13, Iss 1, p 1 (2013)
BMC Cancer
BMC Cancer, Vol 13, Iss 1, p 1 (2013)
Background Breast cancer is a potentially fatal malignancy in females despite the improvement in therapeutic techniques. The identification of novel molecular signatures is needed for earlier detection, monitoring effects of treatment, and predicting
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2528261c6b08fcac65747d7f47f98d52
https://doi.org/10.1186/1471-2407-13-1
https://doi.org/10.1186/1471-2407-13-1